Literature DB >> 18708727

Formula-based estimates of the GFR: equations variable and uncertain.

Pierre Delanaye1, Eric P Cohen.   

Abstract

Regarding the prevalence of chronic kidney disease in the population, estimation of glomerular filtration rate is of importance. Creatinine-based formulas are thus useful as the first step of a prevention strategy. Several creatinine-based formulas have been published. Among these, the Cockcroft-Gault formula and the Modification of Diet in Renal Disease (MDRD) study equation are the most used by physicians. The latter may be automatically reported by laboratories and has thus great success. However, these formulas have limitations. First, the MDRD formulas are not applicable to all populations, notably the healthy one and the patients with abnormal weight (anorectic or obese). Second, we evoke the limitations in the precision of the formulas linked to analytical aspects. Indeed, these analytical limitations remain significant even if they are improved by creatinine standardization. Lastly, we briefly mention the potential impact of these limitations on the epidemiology and the staging of chronic kidney disease. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18708727     DOI: 10.1159/000151436

Source DB:  PubMed          Journal:  Nephron Clin Pract        ISSN: 1660-2110


  20 in total

1.  Worsening renal function defined as an absolute increase in serum creatinine is a biased metric for the study of cardio-renal interactions.

Authors:  Jeffrey M Testani; Brian D McCauley; Jennifer Chen; Michael Shumski; Richard P Shannon
Journal:  Cardiology       Date:  2010-08-03       Impact factor: 1.869

2.  Pharmacokinetics and protein binding of cefazolin in morbidly obese patients.

Authors:  Simone van Kralingen; Margot Taks; Jeroen Diepstraten; Ewoudt M van de Garde; Eric P van Dongen; Marinus J Wiezer; Bert van Ramshorst; Bart Vlaminckx; Vera H Deneer; Catherijne A Knibbe
Journal:  Eur J Clin Pharmacol       Date:  2011-04-16       Impact factor: 2.953

Review 3.  The applicability of eGFR equations to different populations.

Authors:  Pierre Delanaye; Christophe Mariat
Journal:  Nat Rev Nephrol       Date:  2013-07-16       Impact factor: 28.314

4.  A comparison of cystatin C concentrations between patients with chronic interstitial nephritis and glomerular diseases.

Authors:  Nicolas Roberto Robles; Candido Mena; Edgar Chavez; Miguel Angel Bayo; Boris Gonzalez Candia; Antonio Cidoncha; Juan Lopez Gomez; Juan Jose Cubero
Journal:  J Clin Lab Anal       Date:  2017-02-10       Impact factor: 2.352

Review 5.  Time to differentiate 'decreased kidney function' from 'kidney disease': towards improving the definition of chronic kidney disease.

Authors:  Malvinder S Parmar
Journal:  Int Urol Nephrol       Date:  2012-01-05       Impact factor: 2.370

Review 6.  The global burden of chronic kidney disease: estimates, variability and pitfalls.

Authors:  Richard J Glassock; David G Warnock; Pierre Delanaye
Journal:  Nat Rev Nephrol       Date:  2016-12-12       Impact factor: 28.314

7.  MDRD or CKD-EPI study equations for estimating prevalence of stage 3 CKD in epidemiological studies: which difference? Is this difference relevant?

Authors:  Pierre Delanaye; Etienne Cavalier; Christophe Mariat; Nicolas Maillard; Jean-Marie Krzesinski
Journal:  BMC Nephrol       Date:  2010-06-01       Impact factor: 2.388

Review 8.  Renal complications in anorexia nervosa.

Authors:  Chantal Stheneur; Sebastien Bergeron; Anne-Laure Lapeyraque
Journal:  Eat Weight Disord       Date:  2014-07-06       Impact factor: 4.652

9.  Delayed enhancement of ascites after i.v. contrast material administration at CT: time course and clinical correlation.

Authors:  Nancy Benedetti; Rizwan Aslam; Zhen J Wang; Bonnie N Joe; Yanjun Fu; Judy Yee; Benjamin M Yeh
Journal:  AJR Am J Roentgenol       Date:  2009-09       Impact factor: 3.959

10.  Prevalence of chronic kidney disease in Thai adults: a national health survey.

Authors:  Leena Ong-Ajyooth; Kriengsak Vareesangthip; Panrasri Khonputsa; Wichai Aekplakorn
Journal:  BMC Nephrol       Date:  2009-10-31       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.